[1]
Abdelnassir Mohammed Ahamed, Department of Pathology, Faculty of Medicine and Health Sciences, University of West Kordufan, Elnihoud, Sudan.
[2]
Hafiz Ahmed Hobiel, Department of Biochemistry, Faculty of Medicine and Health Sciences, University of West Kordufan, Elnihoud, Sudan.
[3]
Mohammed Saeed Elsammani, Department of Basic Medical Sciences, Faculty of Applied Medical Sciences, University of Albaha, Albaha, Saudi Arabia.
Malaria is a major public health problem in tropical and subtropical countries. P. falciparum and P. vivax are the two major species of malaria infecting humans. Although emphasis on P. falciparum is appropriate, the burden of vivax malaria should be given due attention as almost 40% of the world population are at risk of vivax malaria. This study was aimed to assess the hematological changes in patients with P. falciparum and patients with P. viva malaria. A total of 264 participants (173 P. falciparum and 91 P. vivax) were enrolled in this study, all of them were randomly selected from Elnihoud Teaching Hospital, Elnihoud Locality, West Kordufan State, Sudan. Questionnaire was filled for every participant and thick and thin blood films for malaria were prepared and stained by giemsa stain and the CBC was done by sysmex automated hematological analyzer. The mean Hb level for P. vivax infected patients was significantly lower than that for P. falciparum infected patients (p-value = 0.037). Low TWBCs count was significantly higher among P. vivax infected patients compared to those with P. falciparum infection (p-value = 0.018). Low MCH was significantly higher among P. vivax infected patients compared to those with P. falciparum infection (p-value = 0.019). Hb was positively and significantly correlated with MCV and MCH (p-value < 0.0001 for both). Both P. falciparum and P. vivax can cause hematological changes. Leucopenia was significantly predominant among P. falciparum infected patients and hypochromic anemia was significant predominant among P. vivax infected patients.
Falciparum Malaria, Thrombocytopenia, Leucopenia, Hypochromic Anemia
[1]
WHO (2017) World Malaria Report 2016. Geneva World Health Organization.
[2]
Adam, I., Yassin, I. and Gasim, I. (2018) Efcacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis Malaria Journal Volunme (110).
[3]
WHO (2017) Malaria country profles 2016: Sudan. Geneva World Health Organization.
[4]
WHO (2013) World Malaria Report 2013. Geneva World Health Organiation.
[5]
Douglas, N. M., Simpson, J. A., Phyo, A. P., Siswantoro, H., Hasugian, A. R., Kenangalem, E., Poespoprodjo, J. R., Singhasivanon, P., Anstey, N. M., White, N. J., Tjitra, E., Nosten, F. and Price, R. N. (2013) Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax J Infect Dis Volunme (5): 801-812.
[6]
Sudan, G. o. (2013) National Malaria Control Programme Sudan Malaria Programme Performance Review Aide Memoire Volunme.
[7]
McKenzie, F., Jeffery, G. and Collins, W. (2002) Plasmodium vivax blood-stage dynamics J Parasitol Volunme 521-535.
[8]
Fernandes, Carvalho, L., Zanini, G., A., V., Souza, J., Cotias, P., Silva-Filho, I. and Daniel-Ribeiro, C. (2008) Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region Clin Vaccine Immunol Volunme 650-658.
[9]
Prommano, O., Chaisri, U., Turner, G., Wilairatana, P., Ferguson, D., Viriyavejakul, P., White, N. and Pongponratn, E. (2005) A quantitative ultrastructural study of the liver and the spleen in fatal falciparum malaria Southeast Asian J Trop Med Public Health Volunme 1359-1370.
[10]
Douglas, N., Anstey, N., Buffet, P., Poespoprodjo, J., Yeo, T., White, N. and Price, R. (2012) The anaemia of Plasmodium vivax malaria Malaria Journal Volunme (135).
[11]
WHO (2008) World malaria report. Geneva World Health Organization Volunme.
[12]
Gurjeet, S., Urhekar, A., Ujwala, M. and Sangeeta, S. (2014) Effects of malarial parasitic infections on human blood cells International Journal of Current Microbiology and Applied Sciences Volunme (12): 622-632.
[13]
Ameekumari, P., Sudha, J., Bhavin, P. and Bhautik, M. (2013) Hematological Changes In P. Falciparum & P. Vivax Malaria National Journal of Medical Research Volunme (2).
[14]
Jason J, D., Jayaprakash, C., Prema, D., Thomas, G., Soniya, A., Sucharitha, S. and Manjeshwar S, B. (2017) Comparative hematological changes in malarial infection by P. vivax and P. falciparum: Observations from the endemic region of Mangalore, India International Journal of Applied Research Volunme (6): 179-183.
[15]
Pradhan, M. and Pradeep, J. (2013) Hematological aspects in malaria Medical Journal of Dr. D. Y. Patil University Volunme (2).
[16]
Shraddha, G., Hardik, M., Nayana, L. and Ashok, A. (2015) Study of prevalence of different species of malarial parasites and comparison of hematological parameters in different malarial parasite species International Journal of Medical Science and Public Health Volunme (12).
